Who we are
Omet Pharma is a European generics pharmaceutical company serving the Nordic region, with a strong focus on Scandinavia. Founded in 2020 by a team of former Actavis colleagues, we are dedicated to building successful, long-term partnerships with pharmaceutical manufacturers and suppliers worldwide. Together, we bring affordable, high-quality generic medicines to patients across Sweden, Denmark, Finland and Iceland, with Norway launching in 2027.
We combine an entrepreneurial, agile approach with deep expertise in the Nordic pharmaceutical markets, with a leadership team drawn from Actavis, Teva, Orion, Glenmark and Amgen based across Sweden, Denmark, Switzerland and Bulgaria. Our partnerships are built around four core principles: simplicity, transparency, quality and trust.
Why partner with us
A dedicated, well-connected Nordic partner
For suppliers and manufacturers, Omet is a focused route into the Nordic region, with a strong focus on Scandinavia. Our experienced commercial team brings deep tender, regulatory and supply-chain expertise to market access, tender submissions and product launches across Sweden, Denmark, Finland, Iceland and Norway (launching 2027), backed by long-term, transparent partnerships.
Reliable supply of quality-assured medicines
For pharmacists and prescribers, we work to keep affordable, high-quality generic medicines available and compliant, with clear routes for product enquiries, side-effect reporting and quality concerns.
Affordable medicines, held to a high standard
For patients, our purpose is simple: getting affordable medicine to the people who need it, while we continuously monitor the safety and efficacy of every product we bring to market.
For our manufacturing partners, Omet Pharma offers more than market access. We provide a reliable, transparent and commercially focused partnership, with the local market expertise and operational capabilities needed to build sustainable business together.
We are open to mutually beneficial partnerships with manufacturers who share our commitment to quality, reliability and sustainable growth.
pl. ii
What we are built on
Our aim is to be the trusted gateway to the Nordic markets for pharmaceutical companies committed to making high-quality, affordable medicines accessible to all.
We pursue this for the benefit of all our stakeholders, guided by four core principles.
Simplicity
Keeping how we work clear and uncomplicated.
Transparency
Open with partners, patients and each other.
Quality
Attention to detail at every step of the chain.
Trust
Earned with suppliers, regulators and patients.
The Nordic markets, with their diverse and complex tender systems, can be challenging to navigate. Success requires local expertise, attention to detail and, above all, teamwork. Every contribution counts, and even the smallest details can make a meaningful difference.
Why “Omet Pharma”?
This philosophy is reflected in our name, OMET, derived from the Latin phrase Omnia Mirari Etiam Tritissima: “find wonder in all things, even the most commonplace.”
Omnia Mirari
Etiam Tritissima
“Find wonder in all things, even the most commonplace.”
The phrase was a motto of the renowned Swedish scientist Carl Linnaeus and reflects a spirit of curiosity and careful observation that remains as relevant today as it was in his time.
For us, it has a simple meaning: see the extraordinary in the ordinary.
History & Milestones
- Omet Pharma founded
- Swedish office opened
- First sales in Sweden
- Bulgarian office opened
- First sales in Denmark
- First sales in Finland & Iceland
- Launching in Norway
Up next
Our Products
The prescription and branded generic portfolio, and the routes Omet Pharma uses to reach each market.